{"product_id":"atrial-fibrillation-treatment-market-global-industry-trends-share-size-growth-opportunity-and-forecast-2023-2028","title":"Atrial Fibrillation Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028","description":"\u003cp\u003eAtrial Fibrillation Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028\u003cbr\u003e\nMarket Overview:\u003c\/p\u003e\n\n\u003cp\u003eThe global atrial fibrillation treatment market size reached US$ 7.0 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 13.7 Billion by 2028, exhibiting a growth rate (CAGR) of 11.73% during 2023-2028.\u003c\/p\u003e\n\n\u003cp\u003eAtrial fibrillation (AFib) refers to a cardiac condition with irregular and rapid heart rate that increases the risks of stroke, heart failure and other heart-related complications. In this condition, the upper (atrial) chambers beat irregularly and out of coordination with the lower (ventricle) chambers of the heart, thereby causing heart palpitations, shortness of breath and fatigue. It can also lead to the development of blood clots that may disrupt the blood flow to other organs. The main types of AFib include paroxysmal, persistent, long-term persistent, and permanent AFib that can be treated with medications and other interventions to adjust the heart’s electrical impulses.\u003c\/p\u003e \n\n\u003cp\u003eThe rising prevalence of cardiovascular diseases (CVDs) is one of the key factors driving the growth of the market. Such disorders are highly prevalent among the geriatric population and individuals suffering from other ailments, such as diabetes, hypertension and cardiovascular diseases (CVDs). This, along with the steadily increasing geriatric population across the globe, is providing a boost to the market growth. Furthermore, the increasing preference for minimally invasive (MI) surgical procedures is also creating a positive impact on the demand for miniaturized surgical devices, implant surgeries and remote nursing. Additionally, various technological advancements, such as the development of catheter ablation devices to remove damaged heart tissues and innovative mapping and recording systems, is acting as another growth-inducing factor. Other factors, including improvements in the healthcare infrastructure and extensive research and development (R\u0026amp;D) activities in the field of medical sciences, are projected to drive the market further.\u003c\/p\u003e\n\n\u003cp\u003eKey Market Segmentation:\u003cbr\u003e\nIMARC Group provides an analysis of the key trends in each sub-segment of the global atrial fibrillation treatment market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on disorder type, treatment type and end-user.\u003c\/p\u003e\n\n\u003cp\u003eBreakup by Disorder Type:\u003c\/p\u003e\n\n\u003cp\u003eParoxysmal Atrial Fibrillation\u003cbr\u003e\nPersistent Atrial Fibrillation\u003cbr\u003e\nPermanent Atrial Fibrillation\u003cbr\u003e\nOthers\u003cbr\u003e\n \u003cbr\u003e\nBreakup by Treatment Type:\u003c\/p\u003e\n\n\u003cp\u003eMedical Procedures\u003cbr\u003e\nSurgical Procedures\u003cbr\u003e\nMaze Surgery\u003cbr\u003e\nCatheter Ablation\u003cbr\u003e\nNon-Surgical Procedures\u003cbr\u003e\nElectric Cardioversion\u003cbr\u003e\nDiagnostic Catheters \u003cbr\u003e\nMapping and Recording Systems\u003cbr\u003e\nCardiac Monitors\u003cbr\u003e\nAccess Devices\u003cbr\u003e\nLeft Atrial Appendage and Closure Devices\u003cbr\u003e\nIntracardiac Echocardiography (ICE) Systems\u003cbr\u003e\nMedication\u003cbr\u003e\nAnticoagulants\u003cbr\u003e\nAnti-Arrhythmics\u003cbr\u003e\n \u003cbr\u003e\nBreakup by End-User:\u003c\/p\u003e\n\n\u003cp\u003eHospitals\u003cbr\u003e\nCardiac Labs\u003cbr\u003e\nAmbulatory Surgical Centers\u003cbr\u003e\nOthers\u003cbr\u003e\n \u003cbr\u003e\nBreakup by Region:\u003c\/p\u003e\n\n\u003cp\u003eNorth America\u003cbr\u003e\nUnited States\u003cbr\u003e\nCanada\u003cbr\u003e\nAsia Pacific\u003cbr\u003e\nChina\u003cbr\u003e\nJapan\u003cbr\u003e\nIndia\u003cbr\u003e\nSouth Korea\u003cbr\u003e\nAustralia\u003cbr\u003e\nIndonesia\u003cbr\u003e\nOthers\u003cbr\u003e\nEurope\u003cbr\u003e\nGermany\u003cbr\u003e\nFrance\u003cbr\u003e\nUnited Kingdom\u003cbr\u003e\nItaly\u003cbr\u003e\nSpain\u003cbr\u003e\nRussia\u003cbr\u003e\nOthers\u003cbr\u003e\nLatin America\u003cbr\u003e\nBrazil\u003cbr\u003e\nMexico\u003cbr\u003e\nOthers\u003cbr\u003e\nMiddle East and Africa\u003cbr\u003e\n \u003cbr\u003e\nCompetitive Landscape:\u003cbr\u003e\nThe report has also analysed the competitive landscape of the market with some of the key players being Abbott Laboratories, Atricure Inc., Biotronik, Boston Scientific Corporation, Cardiofocus Inc., Hansen Medical Inc. (Auris Health), Johnson \u0026amp; Johnson, Siemens Healthineers, Stereotaxis Inc., etc.\u003c\/p\u003e\n\n\u003cp\u003eKey Questions Answered in This Report:\u003cbr\u003e\nHow has the global atrial fibrillation treatment market performed so far and how will it perform in the coming years?\u003cbr\u003e\nWhat has been the impact of COVID-19 on the global atrial fibrillation treatment market?\u003cbr\u003e\nWhat are the key regional markets?\u003cbr\u003e\nWhat is the breakup of the market based on the disorder type?\u003cbr\u003e\nWhat is the breakup of the market based on the treatment type?\u003cbr\u003e\nWhat is the breakup of the market based on the end-user?\u003cbr\u003e\nWhat are the various stages in the value chain of the industry?\u003cbr\u003e\nWhat are the key driving factors and challenges in the industry?\u003cbr\u003e\nWhat is the structure of the global atrial fibrillation treatment market and who are the key players?\u003cbr\u003e\nWhat is the degree of competition in the industry?\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"October, 2023 \/ 145 Pages \/ MCW16255770","offer_id":47650499526962,"sku":null,"price":2999.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/atrial-fibrillation-treatment-market-global-industry-trends-share-size-growth-opportunity-and-forecast-2023-2028","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}